Gujarat Kidney and Super Speciality

GKSL

SectorHealthcare Services

Insights Financials Evidence

‌
‌
‌
‌
‌
‌
‌
‌

‌

‌
‌

‌
‌
‌

‌
‌
‌
‌
‌
‌

Gujarat Kidney and Super Speciality Stock Price - ₹187.37 | Healthcare Services | askfuzz

Announcements

Exchange filings, newest first

28 Sept
3 Sept
1 Sept

Documents by quarter

Results, presentation and transcript tracked for every quarter

Quarterly Result Q1 FY2026-27

10 pages

Annual Reports

Management Discussion, Balance Sheet and more

Annual Reports 2025-26

18 pages

Other Filings

KMP changes, governance and LODR disclosures

DateFilingCategory

30 Sept 2026Gujarat Kidney & Super Speciality Ltd submits voting results and scrutinizer report for 7th AGM held on 28 Sep 2026Record Date

29 Sept 2026Gujarat Kidney & Super Speciality Ltd AGM voting results and scrutinizer report for meeting held on 28 Sep 2026Record Date

28 Sept 2026Gujarat Kidney & Super Speciality Ltd AGM outcome on 28 Sep 2026; adoption of FY26 financials and director appointmentsRecord Date

19 Sept 2026Gujarat Kidney & Super Speciality Ltd corrigendum to Annual Report for FY26 regarding omitted Secretarial Audit Report disclosuresRecord Date

4 Sept 2026Gujarat Kidney & Super Speciality Ltd AGM scheduled on 28 Sep 2026Record Date

3 Sept 2026Gujarat Kidney & Super Speciality Ltd AGM scheduled on 28 Sep 2026Record Date

3 Sept 2026Gujarat Kidney & Super Speciality Ltd annual report for FY26KMP

1 Sept 2026Gujarat Kidney & Super Speciality Ltd AGM scheduled on 28 Sep 2026Record Date

24 Aug 2026Gujarat Kidney & Super Speciality Ltd postal ballot e-voting results for variation in IPO proceeds utilisation on 22 Aug 2026Record Date

24 Aug 2026Gujarat Kidney & Super Speciality Ltd appoints Mrs. Disha Bharpoda as Additional Non-Executive Independent Director on 24 Aug 2026KMP

30 May 2026Gujarat Kidney and Superspeciality Limited Annual Secretarial Compliance Report for FY26 under Regulation 24A scheduled on 30.05.2026Audit Reports

15 May 2026Gujarat Kidney and Super Speciality Limited monitoring agency report for Q4FY26 under Regulation Not Specified scheduled on Not AvailableAudit Reports